Castle Biosciences (CSTL) SEC Filings & 10K Form

$24.33
+1.49 (+6.52%)
(As of 05/3/2024 ET)

Recent Castle Biosciences SEC Filings

DateFilerForm TypeView
05/02/2024
3:15 PM
Castle Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/25/2024
3:54 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2024
11:15 PM
Castle Biosciences (Filer)
Form EFFECT
04/16/2024
3:46 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/12/2024
3:36 PM
Castle Biosciences (Subject)
MAETZOLD DEREK J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/10/2024
3:35 PM
BRADBURY DANIEL (Reporting)
Castle Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/10/2024
3:05 PM
Castle Biosciences (Filer)
Form DEF 14A
04/10/2024
3:07 PM
Castle Biosciences (Filer)
Form DEFA14A
04/10/2024
3:08 PM
Castle Biosciences (Filer)
Form ARS
04/08/2024
3:31 PM
BRADBURY DANIEL (Reporting)
Castle Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/05/2024
3:37 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2024
4:02 PM
BRADBURY DANIEL (Reporting)
Castle Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/28/2024
3:43 PM
Castle Biosciences (Issuer)
Cotton Rodney (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2024
3:30 PM
Castle Biosciences (Issuer)
Cotton Rodney (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/22/2024
4:16 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
4:18 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2024
4:14 PM
Castle Biosciences (Subject)
MAETZOLD DEREK J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/06/2024
4:58 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
5:00 PM
Castle Biosciences (Issuer)
Stokes Frank (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
5:04 PM
Castle Biosciences (Issuer)
Oelschlager Kristen M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
5:07 PM
Castle Biosciences (Issuer)
Juvenal Tobin W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
4:52 PM
BRADBURY DANIEL (Reporting)
Castle Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
6:14 PM
Castle Biosciences (Subject)
MAETZOLD DEREK J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/28/2024
4:08 PM
Castle Biosciences (Filer)
Form S-3
Registration statement under Securities Act of 1933  
02/28/2024
4:15 PM
Castle Biosciences (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/09/2024
3:49 PM
BRADBURY DANIEL (Reporting)
Castle Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2024
11:43 AM
Castle Biosciences (Subject)
WASATCH ADVISORS LP (Filed by)
Form SC 13G/A
02/07/2024
3:19 PM
BRADBURY DANIEL (Reporting)
Castle Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
3:19 PM
BRADBURY DANIEL (Reporting)
Castle Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
6:04 AM
Castle Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/04/2024
4:16 PM
Castle Biosciences (Issuer)
Juvenal Tobin W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2023
3:18 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/22/2023
3:06 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2023
3:46 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/14/2023
4:32 PM
BRADBURY DANIEL (Reporting)
Castle Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/14/2023
4:39 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2023
5:24 PM
Castle Biosciences (Subject)
MAETZOLD DEREK J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/12/2023
6:39 PM
Castle Biosciences (Issuer)
Oelschlager Kristen M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2023
6:28 PM
Castle Biosciences (Issuer)
Juvenal Tobin W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2023
6:33 PM
Castle Biosciences (Issuer)
Stokes Frank (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2023
6:19 PM
BRADBURY DANIEL (Reporting)
Castle Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
The Gold Grab of the Century (Ad)

When central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.

That's why we have released our Free Precious Metals Investment Guide.
12/12/2023
6:23 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/08/2023
3:35 PM
BRADBURY DANIEL (Reporting)
Castle Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/08/2023
3:38 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
4:46 PM
BRADBURY DANIEL (Reporting)
Castle Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
4:49 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2023
3:50 PM
Castle Biosciences (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
12/01/2023
3:43 PM
BRADBURY DANIEL (Reporting)
Castle Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/01/2023
3:30 PM
BRADBURY DANIEL (Reporting)
Castle Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/01/2023
3:34 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2023
3:37 PM
Castle Biosciences (Subject)
MAETZOLD DEREK J (Reporting)
Form 144/A
11/22/2023
3:22 PM
BRADBURY DANIEL (Reporting)
Castle Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2023
3:20 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/09/2023
4:25 PM
Castle Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/02/2023
3:14 PM
Castle Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
09/06/2023
3:40 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/01/2023
3:23 PM
BRADBURY DANIEL (Reporting)
Castle Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/01/2023
3:26 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2023
3:51 PM
Castle Biosciences (Issuer)
Castle Biosciences (Issuer)
Goldberg Ellen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2023
3:41 PM
Caple Kim (Reporting)
Castle Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2023
4:06 PM
BRADBURY DANIEL (Reporting)
Castle Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2023
4:10 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2023
3:48 PM
Castle Biosciences (Issuer)
Goldberg Ellen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2023
3:35 PM
Castle Biosciences (Issuer)
Harrison Miles (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2023
3:38 PM
Castle Biosciences (Issuer)
Goldberg Ellen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2023
3:40 PM
Castle Biosciences (Issuer)
Cole G Bradley (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2023
3:42 PM
Aspinall Mara G. (Reporting)
Castle Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2023
3:44 PM
BRADBURY DANIEL (Reporting)
Castle Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2023
3:46 PM
Caple Kim (Reporting)
Castle Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2023
3:33 PM
Castle Biosciences (Issuer)
Olson Tiffany (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2023
5:02 AM
Castle Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/01/2023
3:16 PM
Castle Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/30/2023
4:55 PM
Castle Biosciences (Issuer)
Harrison Miles (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2023
4:57 PM
Castle Biosciences (Issuer)
Olson Tiffany (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2023
4:38 PM
Aspinall Mara G. (Reporting)
Castle Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2023
4:42 PM
BRADBURY DANIEL (Reporting)
Castle Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2023
4:45 PM
Caple Kim (Reporting)
Castle Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2023
4:48 PM
Castle Biosciences (Issuer)
Cole G Bradley (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2023
4:52 PM
Castle Biosciences (Issuer)
Goldberg Ellen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2023
12:43 PM
Castle Biosciences (Filer)
Form DEFA14A
05/08/2023
3:21 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2023
3:26 PM
BRADBURY DANIEL (Reporting)
Castle Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/04/2023
4:19 PM
BRADBURY DANIEL (Reporting)
Castle Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:CSTL) was last updated on 5/4/2024 by MarketBeat.com Staff

From Our Partners